Welcome to Markets Desk, your end-of-week rundown on the stories moving the needle.
Wall Street is wrapping the week on a cautious note, with S&P five hundred futures pointing to a roughly flat open after two consecutive sessions of gains. Markets appear to be consolidating recent advances, with no single catalyst driving direction heading into the weekend close.
Shifting to biopharma, it was a productive week for the sector. Lantheus and Caribou Biosciences each secured FDA approvals, while Teledyne moved to acquire Varex Imaging, expanding its imaging pipeline. Aura Biosciences announced job cuts as part of a restructuring, and two additional firms reported positive clinical trial readouts, signaling continued momentum in early-stage drug development.
And in sports and dealmaking, Josh Kushner has had quite a fortnight. After his bid to privatize World Cup commercial rights fell apart, the forty-one-year-old venture investor pivoted quickly, reaching a deal alongside former Disney chief Bob Iger to become a co-owner of the Los Angeles Lakers, one of the most valuable franchises in professional sports.
That's the tape. Markets Desk, signing off the floor.
